2020 Annual Meeting | C119 - Peripheral Neuropathy 3: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives

�鶹��ýӳ��

2020 Annual Meeting | C119 - Peripheral Neuropathy 3: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives

Date Monday 04/27/20

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Mario A. Saporta, MD, PhD, F�鶹��ýӳ��

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should become familiar with the diagnostic work-up, including genetic testing, of inherited peripheral neuropathies and receive an update on new breakthroughs in therapy development in the field.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Audience Participation

Event Timeline
03:30 PM - 04:30 PM	Speaker	Genetic Neuropathies Through Clinical Cases Mario A. Saporta, MD, PhD, F�鶹��ýӳ��
04:30 PM - 05:00 PM	Speaker	Interpreting Molecular Testing in CMT: Best Practices and Challenges Mario A. Saporta, MD, PhD, F�鶹��ýӳ��
05:00 PM - 05:30 PM	Speaker	Therapy Development for Genetic Neuropathies: Current Stage and Perspectives John Svaren, PhD

Faculty Disclosures
Mario A. Saporta, MD, PhD, F�鶹��ýӳ��	Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SwanBio. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharnext. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics.
John Svaren, PhD	No disclosure on file